The Netherlands’ biotech sector has already seen an upswing following the relocation of the European Medicines Agency (EMA) to Amsterdam following Brexit, according to an influential figure
The UK is a powerhouse of clinical research but maintaining that leading position – and all the benefits that come with it – in the face of global change requires adaptation.
Labour leader Jeremy Corbyn has included in the party’s election manifesto plans to create a state-run generic drug company to combat excessively high prices for new medicines.
